Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 25, Issue 28, Pages 3704-3721
Publisher
Baishideng Publishing Group Inc.
Online
2019-07-27
DOI
10.3748/wjg.v25.i28.3704
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Direct-Acting Antiviral Therapy not Associated with Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
- (2019) Amit G. Singal et al. GASTROENTEROLOGY
- Direct Antiviral Agents and the Risk of Recurrence of Hepatocellular Carcinoma: Moving on?
- (2019) Jean-Charles Nault et al. GASTROENTEROLOGY
- Direct acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
- (2019) Giuseppe Cabibbo et al. JOURNAL OF HEPATOLOGY
- Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels
- (2018) Gang Huang et al. ANNALS OF SURGERY
- Neoadjuvant radiotherapy provided survival benefit compared to adjuvant radiotherapy for hepatocellular carcinoma
- (2018) Huapeng Lin et al. ANZ JOURNAL OF SURGERY
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study
- (2018) Xiao-feng Zhai et al. CANCER
- Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
- (2018) Zheng Wang et al. CLINICAL CANCER RESEARCH
- Chimeric antigen receptor-engineered T-cell therapy for liver cancer
- (2018) Yang Chen et al. Hepatobiliary & Pancreatic Diseases International
- Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide
- (2018) Delphine Maucort-Boulch et al. INTERNATIONAL JOURNAL OF CANCER
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Adjuvant pegylated interferon therapy improves the survival outcomes in patients with hepatitis-related hepatocellular carcinoma after curative treatment
- (2018) Jiansong Wu et al. MEDICINE
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection
- (2018) Ulrich Spengler PHARMACOLOGY & THERAPEUTICS
- Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
- (2018) Li-Chun Lu et al. Liver Cancer
- Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis
- (2018) Dominik Bettinger et al. Liver Cancer
- Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion
- (2018) Ya-Peng Qi et al. AMERICAN JOURNAL OF SURGERY
- IMbrave150: A randomized phase III study of 1L atezolizumab plus bevacizumab vs sorafenib in locally advanced or metastatic hepatocellular carcinoma.
- (2018) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and clinical activity of 1L atezolizumab + bevacizumab in a phase Ib study in hepatocellular carcinoma (HCC).
- (2018) Stacey Stein et al. JOURNAL OF CLINICAL ONCOLOGY
- A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.
- (2018) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Resection versus Resection with Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma Recurrence
- (2018) Qiang Tao et al. Journal of Cancer
- Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus–Related Hepatocellular Carcinoma
- (2018) Zheng Li et al. JAMA Surgery
- 783TiPCA209-9DX: phase III, randomized, double-blind study of adjuvant nivolumab vs placebo for patients with hepatocellular carcinoma (HCC) at high risk of recurrence after curative resection or ablation
- (2018) M J Jimenez Exposito et al. ANNALS OF ONCOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers
- (2017) Yu-Ju Chu et al. INTERNATIONAL JOURNAL OF CANCER
- Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes
- (2017) Edward Michael Mannina et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- KEYNOTE-240: Randomized phase III study of pembrolizumab versus best supportive care for second-line advanced hepatocellular carcinoma.
- (2017) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab in sorafenib-experienced patients with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis: CheckMate 040 study
- (2017) B. Sangro et al. JOURNAL OF HEPATOLOGY
- Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria
- (2017) Chuan Li et al. JOURNAL OF SURGICAL RESEARCH
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
- (2017) Victor Virlogeux et al. LIVER INTERNATIONAL
- Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis
- (2017) Mingheng Liao et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
- (2017) Jia-Zhou Ye et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA
- (2017) Eliza W. Beal et al. WORLD JOURNAL OF SURGERY
- Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy
- (2017) Min Feng et al. OncoTargets and Therapy
- Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion
- (2017) Liming Wang et al. Oncotarget
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
- (2016) Joseph Ralph Kallini et al. ADVANCES IN THERAPY
- BIOSHARE multicenter neoadjuvant phase 2 study: Results of pre-operative sorafenib in patients with resectable hepatocellular carcinoma (HCC)—From GERCOR IRC.
- (2016) Mohamed Bouattour et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III randomized study of sorafenib plus doxorubicin versus sorafenib in patients with advanced hepatocellular carcinoma (HCC): CALGB 80802 (Alliance).
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
- (2016) Jorge A. Marrero et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- 90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes
- (2016) Robert J. Lewandowski et al. JOURNAL OF SURGICAL ONCOLOGY
- Is Salvage Liver Resection Necessary for Initially Unresectable Hepatocellular Carcinoma Patients Downstaged by Transarterial Chemoembolization? Ten Years of Experience
- (2016) Y. Zhang et al. ONCOLOGIST
- Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
- (2016) Chen Liu et al. World Journal of Surgical Oncology
- Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials
- (2016) Hee Chul Park et al. Liver Cancer
- A Meta-Analysis of Adjuvant Therapy after Potentially Curative Treatment for Hepatocellular Carcinoma
- (2016) Jun Wang et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Antiviral Therapy Improves Postoperative Survival in Patients With Hepatocellular Carcinoma
- (2015) Gang Huang et al. ANNALS OF SURGERY
- Recurrence of Hepatocellular Cancer After Resection
- (2015) Parissa Tabrizian et al. ANNALS OF SURGERY
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels
- (2015) Wei-Hu Wang et al. LIVER INTERNATIONAL
- Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma
- (2015) Fikri Bouazza WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
- (2015) Myeong Jun Song WORLD JOURNAL OF GASTROENTEROLOGY
- Perioperative antiviral therapy improves safety in patients with hepatitis B related HCC following hepatectomy
- (2015) Binhao Zhang et al. International Journal of Surgery
- Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
- (2015) Xingshun Qi et al. Oncotarget
- The Global Burden of Cancer 2013
- (2015) Christina Fitzmaurice et al. JAMA Oncology
- Adjuvant Iodine131Lipiodol after Resection of Hepatocellular Carcinoma
- (2015) Ruelan V. Furtado et al. Journal of Oncology
- Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement
- (2015) Roderich E. Schwarz et al. HPB
- Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study
- (2014) C. C. N. Chong et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
- (2014) Won Sohn et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic Review and Meta-Analysis of Adjuvant I131 Lipiodol after Excision of Hepatocellular Carcinoma
- (2014) Ruelan Furtado et al. ANNALS OF SURGICAL ONCOLOGY
- Epidemiology of hepatocellular carcinoma in the United States: Where are we? Where do we go?
- (2014) Hashem B. El-Serag et al. HEPATOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses
- (2014) Xiang Cheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hepatic Radioembolization as a Bridge to Liver Surgery
- (2014) Arthur J. A. T. Braat et al. Frontiers in Oncology
- Safety and efficacy of adjuvant pegylated interferon therapy for metastatic tumor antigen 1-positive hepatocellular carcinoma
- (2013) Danbi Lee et al. CANCER
- Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
- (2013) Yao-Chun Hsu et al. HEPATOLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study
- (2013) Jianhua Yin et al. JOURNAL OF CLINICAL ONCOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
- (2013) Michael Vouche et al. JOURNAL OF HEPATOLOGY
- Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
- (2013) Maurizio Pompili WORLD JOURNAL OF GASTROENTEROLOGY
- Chemoembolization of Hepatocellular Carcinoma
- (2013) Pasquale Petruzzi et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: A prospective cohort study
- (2012) T. Yang et al. EJSO
- Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
- (2012) Chun-Ying Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ablation of Perivascular Hepatic Malignant Tumors with Irreversible Electroporation
- (2012) T. Peter Kingham et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Stereotactic Hypofractionated Radiation Therapy as a Bridge to Transplantation for Hepatocellular Carcinoma: Clinical Outcome and Pathologic Correlation
- (2011) Alan W. Katz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Complete regression of locally advanced hepatocellular carcinoma induced by sorafenib allowing curative resection
- (2011) Sabine Irtan et al. LIVER INTERNATIONAL
- Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies
- (2011) Yanming Zhou et al. World Journal of Surgical Oncology
- Sequential Transcatheter Arterial Chemoembolization and Portal Vein Embolization versus Portal Vein Embolization Only before Major Hepatectomy for Patients with Hepatocellular Carcinoma
- (2010) Hyunkyung Yoo et al. ANNALS OF SURGICAL ONCOLOGY
- Global Burden of Aflatoxin-Induced Hepatocellular Carcinoma: A Risk Assessment
- (2010) Yan Liu et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?
- (2010) Gilles Boschetti et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2010) Riad Salem et al. GASTROENTEROLOGY
- Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta-analysis
- (2010) Jian-Hong Zhong et al. HEPATOLOGY RESEARCH
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma
- (2010) Ghassan K. Abou-Alfa et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices
- (2010) Meghan G. Lubner et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Morphologic features of advanced hepatocellular carcinoma as a predictor of downstaging and Liver Transplantation: An intention-to-treat analysis
- (2010) Omar Barakat et al. LIVER TRANSPLANTATION
- Advanced Hepatic Ablation Technique for Creating Complete Cell Death: Irreversible Electroporation
- (2010) Edward W. Lee et al. RADIOLOGY
- Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus
- (2009) Bao-Gang Peng et al. AMERICAN JOURNAL OF SURGERY
- A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
- (2009) R. J. Lewandowski et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Adjuvant Intra-arterial Iodine-131-labeled Lipiodol for Resectable Hepatocellular Carcinoma
- (2009) Wan Yee Lau et al. ANNALS OF SURGERY
- Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization
- (2009) Ron C. Gaba et al. ANNALS OF SURGICAL ONCOLOGY
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Results of liver resection in combination with radiofrequency ablation for hepatic malignancies
- (2009) R.M. Eisele et al. EJSO
- Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: A cost-benefit analysis while awaiting data on sorafenib safety
- (2009) Alessandro Vitale et al. HEPATOLOGY
- The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
- (2009) Makoto Chuma et al. JOURNAL OF GASTROENTEROLOGY
- Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2009) Etsuko Hashimoto et al. JOURNAL OF GASTROENTEROLOGY
- Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]
- (2008) K Hoffmann et al. BMC CANCER
- A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma
- (2008) Dong Hui et al. DIGESTIVE AND LIVER DISEASE
- Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis
- (2008) Francis Y. Yao et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started